Evidence map›Paper›PMID 36386641›Full record

ArticleFrontiers in microbiology2022

Ke Ming, Shen Zhuang, Ning Ma, Sha Nan, Qiuhua Li, Mingxing Ding, Yi Ding

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Combatting pulmonary fibrosis withChinese herbal medicines · 2026
    Review
  4. Astragalus polysaccharide mitigates the airway inflammation in bronchial asthma by regulating Hedgehog/NLRP3/GSDMD pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. The role of dietary fibre in lung inflammation: microbiota, metabolites, and immune crosstalk.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  9. Article
  10. Article
  11. Pretreatment withFrontiers in pharmacology · 2025
    Article
  12. Review
  13. Cancer management and research · 2024
    Review
  14. Review
  15. Review
  16. Therapeutic and immune-regulation effects ofFrontiers in veterinary science · 2024
    Article
  17. Role of Danggui Buxue Decoction for the prevention and treatment of cardiovascular and pulmonary diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  18. Review
  19. Modulating effects ofJournal of Zhejiang University. Science. B · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ke MingCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Shen ZhuangCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Ning MaCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Sha NanCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Qiuhua LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Mingxing DingCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Yi DingCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Huazhong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory lung injury is a common respiratory disease with limited therapeutic effects. Increasing opinions approved that prevention is more important than drug treatment for inflammatory lung injury.

Indexed as

anti-inflammationAstragalus polysaccharidesinflammatory lung injuryintestinal microbiotashort chain fatty acids

Identifiers

PMID36386641
PMCPMC9640976
OpenAlexW4307372019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.